scispace - formally typeset
S

Sheida Shahraki

Publications -  12
Citations -  90

Sheida Shahraki is an academic researcher. The author has contributed to research in topics: Chemistry & Internal medicine. The author has an hindex of 2, co-authored 7 publications receiving 19 citations.

Papers
More filters
Journal ArticleDOI

Synthesis, characterization, toxicity and morphology assessments of newly prepared microemulsion systems for delivery of valproic acid

TL;DR: N nano-formulation and characterization of oil-in-water F127/lignin microemulsions are reported to enhance the bioavailability of valproic acid (VPA) and induced evident morphological alterations and were more effective than the free drug in inhibiting the growth of cancer cells.
Journal ArticleDOI

Lignin-Stabilized Doxorubicin Microemulsions: Synthesis, Physical Characterization, and In Vitro Assessments

TL;DR: In this article, lignin (LGN) was employed to prepare novel doxorubicin (DOX)-loaded oil-in-water (O/W) microemulsions with the aim of enhancing the bioavailability of DOX.
Journal ArticleDOI

An Updated Review on Implications of Autophagy and Apoptosis in Tumorigenesis: Possible Alterations in Autophagy through Engineered Nanomaterials and Their Importance in Cancer Therapy

TL;DR: In this article, the authors discuss the signaling pathways involved in autophagy and the significance of the mechanism itself in apoptosis and tumorigenesis while shedding light on possible alterations in autoophagy through engineered nanomaterials and their potential therapeutic applications in cancer.
Journal ArticleDOI

Impact of Proliferator-Activated Receptor γ Gene Polymorphisms on Risk of Schizophrenia: A Case-Control Study and Computational Analyses.

TL;DR: Investigation of the relationship of two polymorphisms in the PPARG gene, rs1801282 C/G, and rs3856806 C/T, to the risk of SCZ in the southeast Iranian population showed thatPPARG rs1821282 and rs 3856806 polymorphisms associate with SCZ susceptibility.
Journal ArticleDOI

Quantitative Assessment of the Effects of IL-1ß -511 C>T Variant on Breast Cancer Risk: An Updated Meta-Analysis of 3331 Cases and 3609 Controls

TL;DR: The data results provide a proof of concept for the association of IL-1β -511C>T with BC risk and larger, well-designed population-based studies are needed to confirm these findings.